A pediatric case of pigmented epithelioid melanocytoma with chromosomal copy number alterations in 15q and 17q and a novel NTRK3-SCAPER gene fusion.
Ben J FriedmanSimon HernandezChelsea FidaiAngela JiangTor A ShwayderShannon CarskadonAleodor A AndeaKelly L HarmsDhananjay ChitaleNallasivam PalanisamyPublished in: Journal of cutaneous pathology (2019)
Pigmented epithelioid melanocytoma (PEM) represents a group of rare, heavily pigmented melanocytic tumors encompassing lesions previously designated as "animal-type melanomas" and "epithelioid blue nevi." Despite the association of multiple such tumors in the setting of Carney complex, most cases of PEM occur spontaneously as solitary neoplasms in otherwise healthy patients. PEM may arise in both children and adults, and has a known propensity to spread to the regional lymph nodes. Despite this latter finding, recurrence at the biopsy site or spread beyond the lymph node basin is exceptionally uncommon. Although the molecular basis for PEM continues to be characterized, findings to date suggest that this category of melanocytic neoplasia has genetic alterations distinct from those seen in common nevi, dysplastic nevi, Spitz nevi, and melanoma. Herein, we present an in-depth clinical, histopathologic, and molecular analysis of a case of PEM occurring on the scalp of a young African American girl found to have a novel NTRK3-SCAPER gene fusion.
Keyphrases
- copy number
- lymph node
- mitochondrial dna
- african american
- genome wide
- end stage renal disease
- dna methylation
- basal cell carcinoma
- ejection fraction
- chronic kidney disease
- sentinel lymph node
- newly diagnosed
- neoadjuvant chemotherapy
- young adults
- peritoneal dialysis
- squamous cell carcinoma
- prognostic factors
- climate change
- optical coherence tomography
- gene expression
- patient reported outcomes
- radiation therapy
- high grade
- patient reported
- genome wide identification